GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » Debt-to-Revenue

Dimed Distribuidora de Medicamentos (BSP:PNVL3) Debt-to-Revenue : 0.23 (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Dimed Distribuidora de Medicamentos's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was R$293 Mil. Dimed Distribuidora de Medicamentos's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was R$943 Mil. Dimed Distribuidora de Medicamentos's annualized Revenue for the quarter that ended in Dec. 2024 was R$5,387 Mil. Dimed Distribuidora de Medicamentos's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 0.23.


Dimed Distribuidora de Medicamentos Debt-to-Revenue Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos Debt-to-Revenue Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.21 0.22 0.23 0.25

Dimed Distribuidora de Medicamentos Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.23 0.25 0.23 0.23

Competitive Comparison of Dimed Distribuidora de Medicamentos's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Debt-to-Revenue falls into.


;
;

Dimed Distribuidora de Medicamentos Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Dimed Distribuidora de Medicamentos's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(292.728 + 943.077) / 4942.462
=0.25

Dimed Distribuidora de Medicamentos's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(292.728 + 943.077) / 5387.092
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Dimed Distribuidora de Medicamentos Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimed Distribuidora de Medicamentos Business Description

Traded in Other Exchanges
N/A
Address
Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos Headlines

No Headlines